Trial intelligence / Profile preview

Fudacyn Injection for Obstructive Esophageal Cancer

CTR20150429Phase 2Active

Sponsor
Fujian Longhua Pharmaceutical
Start
May 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of photogem in esophageal cancer, sponsored by Fujian Longhua Pharmaceutical. Started May 2016; status: active.

02

Drugs

photogem
03

Conditions

esophageal cancer

Beyond the preview

Go deeper on CTR20150429.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20150429.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call